Invesco Perpetual UK Focus PDF Factsheet
Total Page：16
File Type：pdf, Size：1020Kb
FACTSHEET 31 August 2021 Life Fund CM Invesco Perpetual UK Focus Effective from 18th September 2020, the underlying fund Invesco UK Focus Fund merged with This document is provided for the purpose of Invesco UK Opportunities Fund. The Invesco UK Opportunities Fund was previously referred to information only. This factsheet is intended for as Invesco UK Growth Fund, its name was changed on the 17th September 2020. The fund individuals who are familiar with investment aim has not changed and we will continue to refer to CM Invesco Perpetual UK Focus in our terminology. Please contact your financial literature. adviser if you need an explanation of the terms used. This material should not be relied upon Asset Allocation (as at 31/07/2021) as sufficient information to support an UK Equities 86.8% investment decision. The portfolio data on this factsheet is updated on a quarterly basis. Canadian Equities 3.6% French Equities 2.8% Money Market 2.1% Fund Aim Irish Equities 2.0% To achieve long-term capital growth through a portfolio of primarily UK securities. American Emerging Equities 1.8% US Equities 0.9% Basic Fund Information Fund Launch Date 17/01/2005 Fund Size £2.0m Sector ABI UK All Companies ISIN GB00B04QQ507 MEX ID CMIPUL Sector Breakdown (as at 31/07/2021) SEDOL B04QQ50 Financials 18.0% Manager Name Martin Walker Industrials 15.0% Manager Since 01/06/2008 Energy 12.9% Utilities 12.6% Top Ten Holdings Basic Materials 12.0% (as at 31/07/2021) BP 6.5% Consumer Discretionary 10.6% ROYAL DUTCH SHELL 'B' 6.5% Health Care 10.3% ASTRAZENECA 5.0% Telecommunications 4.7% BAE SYSTEMS 4.8% Cash 2.1% VODAFONE 4.7% Other 1.8% BARCLAYS 4.0% SSE 3.7% AVIVA 3.6% Regional Breakdown (as at 31/07/2021) NATIONAL GRID 3.4% GLENCORE 3.2% TOTAL 45.4% The composition of asset mix and asset allocation may change at any time and exclude cash unless otherwise stated Page 1 Past Performance Fund Rating Information 40% Overall Morningstar - Rating Morningstar Analyst Rating 20% FE fundinfo Crown Rating The FE fundinfo Crown Rating relates to this fund. However, the Morningstar ratings are 0% based on the underlying fund. These are supplied by the respective independent ratings agencies and are the latest available at the time this factsheet was issued. Past performance is not a reliable indicator of future results. -20% Sep 16 Dec 17 Mar 19 Jun 20 Sep 21 Other Information 31/08/2016 - 31/08/2021 Powered by data from FE fundinfo The views, opinions and forecasts expressed CM Invesco Perpetual UK Focus in this document are those of the fund manager. Investment markets and conditions ABI UK All Companies can change rapidly and as such the views Past performance is not a guide to future performance. Investment value and income from it may expressed should not be taken as statement of fall as well as rise, as a result of market and currency movements. You may not get back the fact, nor should reliance be placed on these amount originally invested. views when making investment decisions. Discrete Performance For further information contact your local sales office or phone Customer Services on 0345 30/06/2020 - 30/06/2019 - 30/06/2018 - 30/06/2017 - 30/06/2016 - 030 6243 (Life and Pensions) 0345 300 2244 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017 (OEIC). Details are also available at CM Invesco Perpetual 27.3% -10.3% -8.2% 6.8% 25.3% www.clericalmedical.co.uk UK Focus Not all products have access to this fund, ABI UK All Companies 22.5% -11.8% -2.8% 6.7% 19.2% please refer to the relevant product literature. Information is shown as unavailable if prior to the launch of fund. Full terms and conditions are available on request from us using the contact details Cumulative Performance provided. Charges, terms and the selection of funds we make available may change. 31/07/2021 - 31/05/2021 - 31/08/2020 - 31/08/2018 - 31/08/2016 - Information on the general and specific risks 31/08/2021 31/08/2021 31/08/2021 31/08/2021 31/08/2021 associated with investing in this fund is CM Invesco Perpetual 4.7% 1.6% 33.3% 11.6% 34.0% available in the relevant fund guide, or KIID UK Focus where applicable. We may change the investment approach rating for the fund. All ABI UK All Companies 2.6% 3.4% 26.5% 9.1% 27.5% information is sourced from Scottish Widows or Quartile 1 4 1 2 2 the relevant fund management group unless otherwise stated. Source: FE fundinfo as at 31/08/2021 Performance figures are in £ Sterling on a single pricing basis, with income (where applicable) reinvested net of UK tax and net of total annual fund charges. These figures do not include any initial charge or other product charge(s) that may be applicable. Quarterly Fund Manager Review The UK equity market continued its recovery in the second quarter of the year, with the continued successful vaccination rollout combined with the easing of lockdown restrictions giving a boost to the economy. However, as the quarter ended, rising cases of the Delta Covid-19 variant resulted in a delay to the lifting of remaining restrictions in the UK, and moderated gains in equity markets in the UK and across Europe. Positive performance came from strong stock selection in Health Care. Spire Healthcare and Vectura Group were both subject to takeover bids, which underlined the relevance of the fund manager’s philosophy of high-conviction value investing. Recently acquired Smith & Nephew was a further important contributor in this sector. Other strong performers were Travis Perkins, after announcing it expected its full year earnings to be ahead of estimates, Harworth Group, and Sainsbury’s after news that Morrisons had also received a takeover approach. Detractors of relative performance from a sector perspective included Financials, Telecommunications, Industrials and Utilities with stock selection being the main drivers in all three. Barclays, was the single biggest detractor in the quarter, as a result of profit taking after especially strong performance over the preceding 6 months, and also because of increased caution around the spread of the Delta variant. Standard Chartered was further notable detractor among Financials. International Telecoms company Vodafone gave up ground as investors reacted to news surrounding increased levels of capex to drive more growth and higher returns. Within Industrials, aircraft component manufacturer Meggitt remained volatile around sentiment related to the resumption of air travel. Utilities company Centrica was a further notable detractor. Other significant detractors in the quarter included Barratt Developments and Marks & Spencer – again as a result of concern around delays to the lifting of restrictions in the UK. Martin Walker 30/06/2021 The views, opinions and forecasts expressed in this document are those of the fund management house. Investment markets and conditions can change rapidly and as such the views expressed should not be taken as statements of fact, nor should reliance be placed on these views when making investment decisions. Scottish Widows Limited. Registered in England and Wales No. 3196171. Registered Office in the United Kingdom at 25 Gresham Street, London EC2V 7HN. Authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. Financial Services Register number 181655. Page 2.